Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ovarian Neoplasms

  Free Subscription


19.08.2024

1 Am J Surg Pathol
1 Cancer
1 Clin Cancer Res
2 Gynecol Oncol
1 J Natl Cancer Inst
1 Oncogene


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Surg Pathol

  1. DEVINS KM, Young RH
    Embryoid Bodies and Related Proliferations in Ovarian Germ Cell Tumors.
    Am J Surg Pathol. 2024 Jul 4. doi: 10.1097/PAS.0000000000002261.
    PubMed         Abstract available


    Cancer

  2. SULLIVAN MW, Graves S, Adkoli A, Zhou Q, et al
    Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer.
    Cancer. 2024 Aug 16. doi: 10.1002/cncr.35523.
    PubMed         Abstract available


    Clin Cancer Res

  3. SANER FAM, Takahashi K, Budden T, Pandey A, et al
    Concurrent RB1 Loss and BRCA-Deficiency Predicts Enhanced Immunological Response and Long-Term Survival in Tubo-Ovarian High-Grade Serous Carcinoma.
    Clin Cancer Res. 2024 Jun 5. doi: 10.1158/1078-0432.CCR-23-3552.
    PubMed         Abstract available


    Gynecol Oncol

  4. ROSS TL, Na R, Au-Yeung G, DeFazio A, et al
    Are exercise and sitting time during chemotherapy for ovarian cancer associated with treatment-related side-effects, chemotherapy completion and survival?
    Gynecol Oncol. 2024;190:53-61.
    PubMed         Abstract available

  5. YOKOI A, Machida H, Shimada M, Mastuo K, et al
    Efficacy and safety of minimally invasive surgery versus open laparotomy for epithelial ovarian cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2024;190:42-52.
    PubMed         Abstract available


    J Natl Cancer Inst

  6. MYERS ER
    Reducing ovarian cancer mortality through screening: an impossible dream?
    J Natl Cancer Inst. 2024 Aug 12:djae175. doi: 10.1093.
    PubMed        


    Oncogene

  7. ONJI H, Tate S, Sakaue T, Fujiwara K, et al
    Schlafen 11 further sensitizes BRCA-deficient cells to PARP inhibitors through single-strand DNA gap accumulation behind replication forks.
    Oncogene. 2024;43:2475-2489.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.